Literature DB >> 19224147

Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

Frederick Marc Köhler, Judit Boda-Heggemann, Beate Küpper, Dirk Wolff, Hansjörg Wertz, Frank Lohr, Frederik Wenz.   

Abstract

PURPOSE: : To assess the accuracy of the gray-value matching algorithm (XVI, Elekta) when multiple iodine-125 ((125)I) seeds are used as fiducials.
MATERIAL AND METHODS: : A phantom, consisting of a plastic box filled with water-dense material containing about 50 dummy seeds, developed primarily as a manual-skill trainer for (125)I seed implantation was used (Figure 1). The phantom was scanned first with a planning CT (PCT) at a slice thickness of 1 mm, 3 mm and 5 mm and with cone-beam CT (CBCT) to be associated with each reference PCT. Matching was performed with the XVI gray-value algorithm. The isocenter was marked with external markers at PCT. After matching, residual error was determined as the difference between planned isocenter and the isocenter that would have been treated based on the matching process. The procedure was performed twice, once without any manipulation (Figure 2) and once with deformation of the seed-bearing dummy prostate by inserting a plug into the phantom aperture that mimics the rectum (Figure 3).
RESULTS: : For the undeformed phantom the maximal residual error regarding the isocenter after gray-value matching around the seed-bearing region was 0.0 mm in x, y and z directions in case of the PCT with 1 mm thickness. The range of residual error was 0-0.4 mm in case of the PCT with 3 mm and 0-0.8 mm in x, y and z directions in case of 5 mm slice thickness, respectively (Figure 4). For the deformed phantom similar results were obtained (maximum error: 1.1 mm).
CONCLUSION: : The residual error after seed-based matching regarding the phantom isocenter was < 1.1 mm in all cases and for the clinical situation (3 mm slice thickness) always < 0.4 mm. The algorithm is therefore appropriate for precision radiotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19224147     DOI: 10.1007/s00066-009-1887-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

1.  Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?

Authors:  Giuseppe Sanguineti; Matthew L Cavey; Eugene J Endres; Paola Franzone; Salvina Barra; Brent C Parker; Michela Marcenaro; Martin Colman; Stefano Agostinelli; Franca Foppiano; Vito Vitale
Journal:  Strahlenther Onkol       Date:  2006-09       Impact factor: 3.621

2.  Feasibility of fully automated detection of fiducial markers implanted into the prostate using electronic portal imaging: a comparison of methods.

Authors:  Emma J Harris; Helen A McNair; Phillip M Evans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-15       Impact factor: 7.038

3.  A grey-level image alignment algorithm for registration of portal images and digitally reconstructed radiographs.

Authors:  D H Hristov; B G Fallone
Journal:  Med Phys       Date:  1996-01       Impact factor: 4.071

4.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Authors:  M J Zelefsky; Z Fuks; M Hunt; H J Lee; D Lombardi; C C Ling; V E Reuter; E S Venkatraman; S A Leibel
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

5.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI).

Authors:  Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

6.  Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation.

Authors:  Homan Dehnad; Aart J Nederveen; Uulke A van der Heide; R Jeroen A van Moorselaar; Pieter Hofman; Jan J W Lagendijk
Journal:  Radiother Oncol       Date:  2003-06       Impact factor: 6.280

7.  Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: assessment of prostate organ motion.

Authors:  Jergin Chen; R Jeffrey Lee; Diana Handrahan; William T Sause
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-24       Impact factor: 7.038

8.  Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience.

Authors:  John E Sylvester; John C Blasko; Peter D Grimm; Robert Meier; Judith A Malmgren
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

9.  Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT.

Authors:  Cornelia Walter; Judit Boda-Heggemann; Hansjörg Wertz; Iris Loeb; Angelika Rahn; Frank Lohr; Frederik Wenz
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

10.  Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.

Authors:  Hassan Elsayed; Tobias Bölling; Christos Moustakis; Stefan-Bodo Müller; Patrick Schüller; Iris Ernst; Normann Willich; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

View more
  11 in total

1.  Phase-specific cone beam computed tomography reduces reconstructed volume loss of moving phantom.

Authors:  H-L Chao; W-L Chen; C-C Hu; J-K Wu; C-J Wu; J C-H Cheng
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

2.  Treatment results of radiation therapy for muscle-invasive bladder cancer.

Authors:  Tanja Langsenlehner; Carmen Döller; Franz Quehenberger; Heidi Stranzl-Lawatsch; Uwe Langsenlehner; Karl Pummer; Karin S Kapp
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

3.  Comment by J. Schäfer, G. Welzel, F. Wenz on D. Norkus et al. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma. a report on acute toxicity : in: Strahlenther Onkol 2009;185: 715-21 (No. 11) (DOI 10.1007/s00066-009-1982-z).

Authors:  Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-11       Impact factor: 3.621

Review 4.  kV cone-beam CT-based IGRT: a clinical review.

Authors:  Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

5.  [Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer].

Authors:  D Böhmer; F Wenz; T Martin; F Sedlmayr; W Hinkelbein; T Wiegel
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

6.  The German S3 guideline prostate cancer: aspects for the radiation oncologist.

Authors:  Frederik Wenz; Thomas Martin; Dirk Böhmer; Stefan Martens; Felix Sedlmayer; Manfred Wirth; Kurt Miller; Axel Heidenreich; Mark Schrader; Wolfgang Hinkelbein; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

7.  Practically acquired and modified cone-beam computed tomography images for accurate dose calculation in head and neck cancer.

Authors:  Chih-Chung Hu; Wen-Tao Huang; Chiao-Ling Tsai; Jian-Kuen Wu; Hsiao-Ling Chao; Guo-Ming Huang; Chun-Wei Wang; Chien-Jang Wu; Jason Chia-Hsien Cheng
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

Review 8.  Stereotactic radiotherapy in the liver hilum. Basis for future studies.

Authors:  C Zamboglou; M-B Messmer; G Becker; F Momm
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

9.  Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.

Authors:  Michael Pinkawa; Richard Holy; Marc D Piroth; Jens Klotz; Sandra Nussen; Thomas Krohn; Felix M Mottaghy; Martin Weibrecht; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

10.  Radiation protection of persons living close to patients with radioactive implants.

Authors:  Theodor W Kaulich; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.